Glorax Bonds, 001P-05 (4B02-05-16806-A-001P, ГЛОРАКС1Р5, RU000A10E655)
FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST
With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!
Domestic bonds
With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!
Domestic bonds
Everything you need for fixed income research and monitoring.
Explore the most comprehensive database
1 000 000
bonds
100 000
stocks
175 910
ETF & Funds
100 000
indices
Track your portfolio in the most efficient way
full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register|
GloraX is a federal developer specializing in the construction of residential complexes, commercial real estate and social infrastructure facilities.
GloraX is present in 10 regions: Saint Petersburg, Leningrad Region, Moscow, Nizhny Novgorod, Kazan, Yaroslavl, Vladimir, Murmansk, Omsk ...
GloraX is a federal developer specializing in the construction of residential complexes, commercial real estate and social infrastructure facilities.
GloraX is present in 10 regions: Saint Petersburg, Leningrad Region, Moscow, Nizhny Novgorod, Kazan, Yaroslavl, Vladimir, Murmansk, Omsk and Tula. The company's portfolio includes projects in various housing segments: from comfort class to premium class. JSC Glorax was established in 2024 in Moscow. The company is the legal successor of LLC "Glorex". |
|
|
|
|
|
|
| Following Business Day |
Explore the most comprehensive database
1 000 000
bonds
100 000
stocks
175 910
ETF & Funds
100 000
indices
Track your portfolio in the most efficient way
full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register| 2026 | |
| 2025 | |
| 2024 | |